Hahn & Company Acquires Cynosure and Merges It with Lutronic to Form Cynosure Lutronic
January 19, 2024
Hahn & Company completed the acquisition of Cynosure and has combined it with Lutronic (which Hahn had recently acquired) under the newly formed parent Cynosure Lutronic, Inc. The merger creates a global leader in energy‑based medical aesthetic systems with an expanded product portfolio, R&D capabilities and a broader international commercial footprint.
- Buyers
- Hahn & Company
- Targets
- Cynosure, Lutronic
- Industry
- Medical Devices
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
The Cynosure Group Acquires Utah Development and Construction to Form Joint Venture Platform With Clyde Capital Group
February 27, 2026
Real Estate
The Cynosure Group acquired Park City-based Utah Development and Construction (UDC) to create a new development platform jointly owned by Clyde Capital Group and Cynosure Elevations, Cynosure’s real estate investment division. The joint venture will focus on developing hospitality and mixed-use projects in premier resort markets across the Intermountain West.
-
Caldera Medical Acquires UVision 360 and the LUMINELLE Product Family
October 8, 2024
Medical Devices
Caldera Medical has acquired UVision 360, the developer of the LUMINELLE hysteroscopy and cystoscopy systems, expanding its minimally invasive women's health device portfolio. The deal brings the LUMINELLE product family — including the new LUMINELLE Bx on-demand biopsy technology — into Caldera's commercial infrastructure to broaden office-based and surgical hysteroscopy capabilities.
-
Hahn & Company and Lutronic CEO Haelyung Hwang Launch Tender Offer to Acquire Lutronic
June 14, 2023
Medical Devices
South Korean private equity firm Hahn & Company has signed definitive agreements with Lutronic founder and CEO Haelyung Hwang to jointly launch a tender offer for all remaining shares of Lutronic for KRW957.0 billion (US$735.9 million). Lutronic is a South Korea–based maker of aesthetic medical devices with 2022 revenues of over KRW264 billion and a growing global presence, particularly in the United States and Europe.
-
The Cynosure Group Makes Growth Investment in Fresh Consulting
December 30, 2021
IT Services
Seattle-area technology consulting firm Fresh Consulting received a strategic growth investment from The Cynosure Group. The minority capital injection will support Fresh's capability expansion (including internal development and M&A) while the company's founders and management remain majority owners.
-
Clayton, Dubilier & Rice to Acquire Cynosure from Hologic
November 20, 2019
Medical Devices
Clayton, Dubilier & Rice (CD&R) has agreed to acquire Cynosure, LLC, a leading developer and manufacturer of medical aesthetic treatment systems, from Hologic, Inc. The transaction is a divestiture of Hologic’s aesthetic devices business and will enable CD&R to invest behind Cynosure’s product portfolio, expand sales and marketing, and pursue tuck-in acquisitions to accelerate growth.
-
ALPHAEON Acquires LENSAR
November 16, 2015
Medical Devices
ALPHAEON Corporation has agreed to acquire substantially all assets of LENSAR, Inc. in a transaction valued at up to $59 million in cash, stock and assumed debt. The deal brings LENSAR’s femtosecond cataract laser technology into ALPHAEON’s lifestyle healthcare portfolio and expands ALPHAEON’s ophthalmology offering for its global network of ophthalmologists.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.